Kymriah (Tisagenlecleucel)

Complete patient guide for uses, dosage, side effects, and safety information

Prescription Required

Quick Facts

Generic Name
Tisagenlecleucel
Drug Class
Genetically modified cell therapy
Used For
Treatment of B-cell precursor acute lymphoblastic leukaemia (B-cell ALL) in children and young adults, and relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) in adults.
How Taken
Infusion through a vein, administered as a one-time treatment.

What Is Kymriah Used For?

Kymriah is a personalized medicine made from your own T-cells, designed to help your immune system target and destroy cancer cells.

Primary Uses

Kymriah is used to treat children and young adults up to 25 years with refractory or relapsed B-cell precursor acute lymphoblastic leukaemia (B-cell ALL), and adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) after two or more lines of systemic therapy.

How It Works

The T-cells are modified with a new gene that enables them to recognize and attack cancer cells in the body.

Good to know: Kymriah is a personalized treatment that uses your own immune cells.

Continue Reading

Sign in to access the complete medication guide including dosage, side effects, warnings, and more.

How to Take Kymriah

Kymriah is administered as a single infusion at a specialized treatment center.

Dosage Instructions

Kymriah is prepared specifically for you from your own T-cells, which are collected and modified before being infused back into your body. The infusion typically takes less than one hour.

What If You Miss a Dose?

Kymriah is given as a one-time treatment; therefore, missing a dose does not apply.

Important: Kymriah is a one-time treatment and should not be repeated unless specifically directed by your healthcare provider.

Side Effects

Like all medications, this medicine can cause side effects. Most are mild and temporary, but some require medical attention.

Common Side Effects

These side effects occur relatively frequently and usually don’t require emergency care:

  • Infusion reactions (fever, chills, nausea, vomiting, tiredness)
  • Loss of appetite
  • Headache
  • Dizziness
  • Muscle weakness
  • Rash

Seek immediate medical attention if you experience:

  • Cytokine Release Syndrome (CRS)
  • Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS)
  • Severe infections
  • Blood disorders
  • Heart failure

Impulse Control Issues

No specific impulse control issues mentioned.

Important Warnings

There are significant risks associated with Kymriah treatment, including serious side effects.

Who Should Not Take Kymriah

Do not use Kymriah if you have had an allergic reaction to tisagenlecleucel or any of its components.

Medical Conditions to Discuss

Discuss any history of infections, heart or lung problems, recent vaccinations, or if you are pregnant or breastfeeding with your doctor.

Pregnancy and Breastfeeding

Kymriah is not recommended during pregnancy, and women should use effective birth control after treatment. The effects on breastfeeding are unknown.

Elderly Patients With Dementia: Special caution is advised for elderly patients, particularly those with dementia.

Drug Interactions

Certain medications may interfere with Kymriah's effectiveness.

Grapefruit interaction: No specific grapefruit interaction mentioned.

  • Corticosteroids
  • Live vaccines

Alcohol & Driving

Avoid alcohol and activities requiring alertness after receiving Kymriah.

Alcohol

No specific alcohol warnings mentioned, but caution is advised.

Driving and Operating Machinery

Do not drive or operate heavy machinery for at least 8 weeks after treatment due to potential side effects.

Temperature Regulation

No specific temperature regulation warnings mentioned.

Storage

Kymriah must be stored at or below minus 120°C until it is ready for use.

Overdose Information

Overdose information is not applicable as Kymriah is administered as a one-time infusion.

Frequently Asked Questions

The effects of Kymriah can typically be seen within the first few weeks after infusion.

There are no specific dietary restrictions mentioned for Kymriah.

Kymriah is not considered addictive.

Kymriah is a one-time treatment, so stopping is not applicable.

It is advisable to avoid alcohol, especially in the weeks following treatment.

Weight gain is not specifically mentioned as a side effect of Kymriah.

Elderly patients should use caution and discuss their health status with their doctor before treatment.

Kymriah is given as a single infusion, so missing a dose does not apply.

Important Disclaimer

This information is intended for general educational purposes only and should not be considered medical advice. Always consult your healthcare provider or pharmacist before starting, stopping, or changing any medication.

If you think you may have a medical emergency, call your doctor or emergency services immediately.

Create a free account to access the full medication guide.

Sign in to access your medication guides.